On the other hand, some previous reports suggest that CD44 could interact not only with EGFR but also with HER2 in cancer cells.31–33 Considering these observations, we could speculate that the CD44v regulation by receptor tyrosine kinases could depend on cell types or cell context. This evidence concerns the gene ERBB2 and cancer.